Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning for Younger Patients with Hematologic Malignancies.
HEMATOLOGIC MALIGNANCIES
treatment-related mortality and engraftment, all cause mortality
regimen-related toxicities, graft-versus-host-disease, relapse, and overall survival., Time point(s) at which outcome measure is assessed.
Primary end points are treatment-related mortality and engraftment. Secondary end points are regimen-related toxicities, graft-versus-host-disease, relapse, and overall survival.